| UniProt ID | RAE1_HUMAN | |
|---|---|---|
| UniProt AC | P24386 | |
| Protein Name | Rab proteins geranylgeranyltransferase component A 1 | |
| Gene Name | CHM | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 653 | |
| Subcellular Localization | Cytoplasm, cytosol . | |
| Protein Description | Substrate-binding subunit of the Rab geranylgeranyltransferase (GGTase) complex. Binds unprenylated Rab proteins and presents the substrate peptide to the catalytic component B composed of RABGGTA and RABGGTB, and remains bound to it after the geranylgeranyl transfer reaction. The component A is thought to be regenerated by transferring its prenylated Rab back to the donor membrane. Besides, a pre-formed complex consisting of CHM and the Rab GGTase dimer (RGGT or component B) can bind to and prenylate Rab proteins; this alternative pathway is proposed to be the predominant pathway for Rab protein geranylgeranylation.. | |
| Protein Sequence | MADTLPSEFDVIVIGTGLPESIIAAACSRSGRRVLHVDSRSYYGGNWASFSFSGLLSWLKEYQENSDIVSDSPVWQDQILENEEAIALSRKDKTIQHVEVFCYASQDLHEDVEEAGALQKNHALVTSANSTEAADSAFLPTEDESLSTMSCEMLTEQTPSSDPENALEVNGAEVTGEKENHCDDKTCVPSTSAEDMSENVPIAEDTTEQPKKNRITYSQIIKEGRRFNIDLVSKLLYSRGLLIDLLIKSNVSRYAEFKNITRILAFREGRVEQVPCSRADVFNSKQLTMVEKRMLMKFLTFCMEYEKYPDEYKGYEEITFYEYLKTQKLTPNLQYIVMHSIAMTSETASSTIDGLKATKNFLHCLGRYGNTPFLFPLYGQGELPQCFCRMCAVFGGIYCLRHSVQCLVVDKESRKCKAIIDQFGQRIISEHFLVEDSYFPENMCSRVQYRQISRAVLITDRSVLKTDSDQQISILTVPAEEPGTFAVRVIELCSSTMTCMKGTYLVHLTCTSSKTAREDLESVVQKLFVPYTEMEIENEQVEKPRILWALYFNMRDSSDISRSCYNDLPSNVYVCSGPDCGLGNDNAVKQAETLFQEICPNEDFCPPPPNPEDIILDGDSLQPEASESSAIPEANSETFKESTNLGNLEESSE | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 4 | Phosphorylation | ----MADTLPSEFDV ----CCCCCCCCCCE | 30.91 | 23663014 | |
| 7 | Phosphorylation | -MADTLPSEFDVIVI -CCCCCCCCCCEEEE | 54.75 | 23663014 | |
| 16 | Phosphorylation | FDVIVIGTGLPESII CCEEEECCCCCHHHH | 25.15 | 23663014 | |
| 21 | Phosphorylation | IGTGLPESIIAAACS ECCCCCHHHHHHHHC | 19.84 | 23663014 | |
| 28 | Phosphorylation | SIIAAACSRSGRRVL HHHHHHHCCCCCEEE | 25.42 | 23663014 | |
| 30 | Phosphorylation | IAAACSRSGRRVLHV HHHHHCCCCCEEEEE | 21.98 | 27762562 | |
| 39 | Phosphorylation | RRVLHVDSRSYYGGN CEEEEEECCCCCCCC | 23.26 | - | |
| 70 | Phosphorylation | QENSDIVSDSPVWQD HHCCCCCCCCCHHHH | 32.48 | 28348404 | |
| 72 | Phosphorylation | NSDIVSDSPVWQDQI CCCCCCCCCHHHHHH | 17.53 | 28348404 | |
| 89 | Phosphorylation | NEEAIALSRKDKTIQ CHHHHHHHCCCCCCC | 28.41 | 24719451 | |
| 131 | Phosphorylation | LVTSANSTEAADSAF EEECCCCCHHHHCCC | 29.47 | 24275569 | |
| 145 | Phosphorylation | FLPTEDESLSTMSCE CCCCCCCCCCCCCHH | 39.68 | 29759185 | |
| 190 | Phosphorylation | DDKTCVPSTSAEDMS CCCCCCCCCCHHHHH | 18.01 | 28555341 | |
| 191 | Phosphorylation | DKTCVPSTSAEDMSE CCCCCCCCCHHHHHC | 26.36 | 28985074 | |
| 222 | Ubiquitination | ITYSQIIKEGRRFNI CCHHHHHHCCCCCCH | 56.60 | - | |
| 233 | Phosphorylation | RFNIDLVSKLLYSRG CCCHHHHHHHHHHCC | 25.53 | 24043423 | |
| 237 | Phosphorylation | DLVSKLLYSRGLLID HHHHHHHHHCCHHHH | 13.52 | 19835603 | |
| 238 | Phosphorylation | LVSKLLYSRGLLIDL HHHHHHHHCCHHHHH | 21.60 | 19835603 | |
| 249 | Phosphorylation | LIDLLIKSNVSRYAE HHHHHHHCCHHHHHH | 35.16 | 30622161 | |
| 252 | Phosphorylation | LLIKSNVSRYAEFKN HHHHCCHHHHHHHCC | 24.67 | 30622161 | |
| 254 | Phosphorylation | IKSNVSRYAEFKNIT HHCCHHHHHHHCCHH | 11.72 | 22817900 | |
| 305 | Phosphorylation | FLTFCMEYEKYPDEY HHHHHHHHHHCCCCC | 7.28 | 22817900 | |
| 323 | Phosphorylation | EEITFYEYLKTQKLT EEEEHHHHHHHCCCC | 11.34 | 22468782 | |
| 330 | Phosphorylation | YLKTQKLTPNLQYIV HHHHCCCCCCHHHEE | 19.71 | 22468782 | |
| 403 | O-linked_Glycosylation | GIYCLRHSVQCLVVD HHHHHHHCEEEEEEE | 13.88 | 30620550 | |
| 466 | Phosphorylation | TDRSVLKTDSDQQIS ECCCEECCCCCCCEE | 36.25 | 24719451 | |
| 468 | Phosphorylation | RSVLKTDSDQQISIL CCEECCCCCCCEEEE | 42.42 | 24719451 | |
| 484 | Phosphorylation | VPAEEPGTFAVRVIE EECCCCCCEEHHHHH | 21.09 | 24719451 | |
| 494 | Phosphorylation | VRVIELCSSTMTCMK HHHHHHHHCCCEECC | 41.28 | - | |
| 495 | Phosphorylation | RVIELCSSTMTCMKG HHHHHHHCCCEECCC | 22.62 | - | |
| 503 | Phosphorylation | TMTCMKGTYLVHLTC CCEECCCEEEEEEEE | 14.25 | 24043423 | |
| 504 | Phosphorylation | MTCMKGTYLVHLTCT CEECCCEEEEEEEEC | 18.52 | 24043423 | |
| 509 | Phosphorylation | GTYLVHLTCTSSKTA CEEEEEEEECCCCHH | 10.00 | 24043423 | |
| 511 | Phosphorylation | YLVHLTCTSSKTARE EEEEEEECCCCHHHH | 30.69 | 24043423 | |
| 512 | Phosphorylation | LVHLTCTSSKTARED EEEEEECCCCHHHHH | 31.80 | 24043423 | |
| 513 | Phosphorylation | VHLTCTSSKTAREDL EEEEECCCCHHHHHH | 18.84 | 24043423 | |
| 651 | Phosphorylation | NLGNLEESSE----- CCCCCCCCCC----- | 30.32 | 25159151 | |
| 652 | Phosphorylation | LGNLEESSE------ CCCCCCCCC------ | 51.08 | 25159151 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of RAE1_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RAE1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RAE1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| RAB1A_HUMAN | RAB1A | physical | 8294464 | |
| RAB3A_HUMAN | RAB3A | physical | 8294464 | |
| RAB5A_HUMAN | RAB5A | physical | 8294464 | |
| RAB6A_HUMAN | RAB6A | physical | 8294464 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| 303100 | Choroideremia (CHM) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-651 AND SER-652, ANDMASS SPECTROMETRY. | |
| "Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-305, AND MASSSPECTROMETRY. | |